Harvard Business Review

DECEMBER 20, 2011

The two biggest product stories of 2011 were arguably Lipitor and the iPhone 4S. In both instances, the life-cycle management innovation involves using disintermediation to change how the customer interacts with the product. 30) of a blockbuster prescription drug. And both teach lessons that apply across many industries.

Disintermediation 15

Disintermediation Industry Pharmaceuticals Price 15

Harvard Business Review

MAY 20, 2014

The rate of business formation in 2011 was almost half of what it was in 1978, with the rate of dissolution somewhat higher than the past couple decades. In pharmaceuticals, the largest company, Pfizer, is the result of decades of mergers. Consolidation of the financial sector has led to similar dynamics in other industries.

Pharmaceuticals 11

Pharmaceuticals Banking Chemicals Trends 11

Harvard Business Review

DECEMBER 27, 2016

A study published in 2011 examined CEOs in the top-100 best hospitals in USNWR in three key medical specialties: cancer, digestive disorders, and cardiovascular care. But we would argue that credibility may also be signaled to important external stakeholders — future employees, patients, the pharmaceutical industry, donors, and so on.

Management 15

Management 360-Degree Feedback Mayo Training 15

Harvard Business Review

MAY 17, 2012

Enter jugaad innovation — a cost-effective approach for creating affordable products and services using limited resources. In 2011, Embrace piloted the product in India, where 1.2 For us, innovation is a dynamic process that never ends.''. million premature babies die each year. Early results have been very encouraging.

Incubator 11

Incubator Business Model Entrepreneur Cost 11

Harvard Business Review

JUNE 16, 2016

The initial breakthrough came in 1987, but the first drug wasn’t approved until 2011. The Institute for Applied Cancer Science at MD Anderson (IACS) is exploring revolutionary new cures and the National Network for Manufacturing Innovation (NNMI) is working to revive the US production capacity. Innovating the Innovation Process.

Technology 8

Technology Venture Capitalist Supply Chain Innovation 8

Harvard Business Review

MARCH 2, 2012

In 2011, 71% of HBS's new cases were written about foreign companies. French pharmaceutical company Sanofi recently acquired Boston-based Genzyme to tap into America's intellectual capital in biotechnology. America fosters risk-taking and innovation by entrepreneurs who become global leaders.

Competitive Advantage 13

Competitive Advantage Globalization Development Intellectual Capital 13

Strategy Driven

MARCH 18, 2011

Copyright 2007-2011 by StrategyDriven, Inc. It divested a number of personal care and confectionary lines (e.g., Schick razors and Trident) and acquired other products (e.g., Purell) consistent with its chosen way to play. To learn more about Capabilities-Driven Strategy, click here. All rights reserved.

Resources 52

Resources Industry System Strategy 52

Harvard Business Review

DECEMBER 14, 2015

They want to see how these approaches … are truly beneficial to existing priorities like retention, talent advancement, innovation.” Chirag Patel, CEO of Amneal Pharmaceuticals and Ernst & Young 2011 Entrepreneur of the Year, credits meditation with helping him feel more connected to his clients.

CEO 8

CEO Emotional Intelligence Cooper Pharmaceuticals 8

Harvard Business Review

SEPTEMBER 5, 2013

In 2011, Thierry Andretta, the CEO of French fashion company Lanvin, announced an initiative called "no email Wednesdays" because he thought people had stopped actually talking to each other. Marissa Mayer, Yahoo''s CEO, ended the company''s work-from-home policy to foster a more collaborative, innovative environment.

Productivity 8

Productivity Products Peer Review Short-term 8

Strategy Driven

JANUARY 24, 2011

Closing the Execution Gap : How Great Leaders and Their Companies Get Results by Richard Lepsinger If an organization can’t execute its plans and initiatives, nothing else matters: not the most solid, well thought-out strategy, not the most innovative business model, not even technological breakthroughs that could transform an industry.

Execution 67

Execution Company 360-Degree Feedback Cooper 67

Harvard Business Review

NOVEMBER 2, 2018

Workers’ increasing out-of-pocket costs are creating widespread discontent with the underlying costs of care — a problem largely driven by the high prices charged to private payers for health services and pharmaceuticals. Between 2011 and 2017, employees’ premiums and deductibles grew faster than their median income.

Health Care 8

Health Care Cost Insurance Price 8

Harvard Business Review

NOVEMBER 20, 2015

Compliance is crucial for pharmaceutical makers such as Abbott and Amgen – a “ Form 483 ” warning from an FDA inspector can shut down a drug facility in an instant and even land top executives in jail. In 2011, Havens’ collaboration with IBM procurement paid off, winning Havens four significant projects.

Supply Chain 8

Supply Chain Collins Golden Handcuff Pharmaceuticals 8

Harvard Business Review

MAY 10, 2013

The pressure on the company by the investing community (among others) was so severe that it eventually split into two, Motorola Mobility and Motorola Solutions in January of 2011. Such a pattern is well established in the pharmaceutical industry as large established firms partner with smaller biotech firms.

Venture Capitalist 8

Venture Capitalist Restructuring Competitive Advantage Short-term 8

Harvard Business Review

NOVEMBER 21, 2013

Wyeth, a pharmaceutical acquired by Pfizer in 2009, was the sole supplier of Premarin. Why do some companies choose to patent their innovation while others choose to hide it? When facing the choice of patenting or hiding a valuable innovation, you must first ask yourself whether the invention is patentable at all.

Intangible Assets 8

Intangible Assets Merchandising Innovation Pharmaceuticals 8

Harvard Business Review

JUNE 21, 2017

Precision medicine innovations are driven by complex analysis of massive data sets, with researchers querying data derived from thousands of patients for each cancer type. How the most innovative providers are creating value. Insight Center. The Leading Edge of Health Care. Sponsored by Optum.

Metrics 8

Metrics Health Care Learning-by-Doing Education 8

Harvard Business Review

MARCH 4, 2011

And that should make it easier for IBM to sell the question-answering technology in hospitals, law firms, pharmaceutical labs, call centers, and every other area in which people are grappling with finding answers in ever larger sets of data. This kind of defensive analysis no doubt provided some comfort to the public.

Learning Curve 12

Learning Curve Pharmaceuticals Call Center Technology 12

Harvard Business Review

SEPTEMBER 11, 2014

Finally, industries in the upper-right quadrant — such as software, pharmaceuticals, and medical equipment — face high uncertainty in both demand and technology. In other words, if you are in a high uncertainty industry, you must excel at innovation…or die. Customers Innovation Technology'

Uncertainty 22

Uncertainty Industry Bottom-up Technology 22

Harvard Business Review

MAY 25, 2017

How the most innovative providers are creating value. In 2011 81 digital health startups received venture funding; with consistent year-over-year increases, 296 startups were venture backed in 2016. But technology has become rooted firmly in U.S. health care and, as elsewhere, consumers will choose many of the winners. Insight Center.

Health Care 9

Health Care Trends Venture Funding Technology 9